首页> 美国卫生研究院文献>Molecular and Cellular Biology >Involvement of Proteasome α-Subunit PSMA7 in Hepatitis C Virus Internal Ribosome Entry Site-Mediated Translation
【2h】

Involvement of Proteasome α-Subunit PSMA7 in Hepatitis C Virus Internal Ribosome Entry Site-Mediated Translation

机译:蛋白酶体α亚基PSMA7参与丙型肝炎病毒内部核糖体进入位点介导的翻译。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ribozymes are small catalytic RNA molecules that can be engineered to enzymatically cleave RNA transcripts in a sequence-specific fashion and thereby inhibit expression and function of the corresponding gene product. With their simple structures and site-specific cleavage activity, they have been exploited as potential therapeutic agents in a variety of human disorders, including hepatitis C virus (HCV) infection. We have designed a hairpin ribozyme (Rz3′X) targeting the HCV minus-strand replication intermediate at position 40 within the 3′X tail. Surprisingly, Rz3′X was found to induce ganciclovir (GCV)-resistant colonies in a bicistronic cellular reporter system with HCV internal ribosome entry site (IRES)-dependent translation of herpes simplex virus thymidine kinase (TK). Rz3′X-transduced GCV-resistant HeLa reporter cells showed substantially reduced IRES-mediated HCV core protein translation compared with control vector-transduced cells. Since these reporter systems do not contain the HCV 3′X tail sequences, the results indicate that Rz3′X probably exerted an inhibitory effect on HCV IRES activity fortuitously through another gene target. A novel technique of ribozyme cleavage-based target gene identification (cleavage-specific amplification of cDNA ends) (M. Krüger, C. Beger, P. J. Welch, J. R. Barber, and F. Wong-Staal, Nucleic Acids Res. 29:e94, 2001) revealed that human 20S proteasome α-subunit PSMA7 mRNA was a target RNA recognized and cleaved by Rz3′X. We then showed that additional ribozymes directed against PSMA7 RNA inhibited HCV IRES activity in two assay systems: GCV resistance in the HeLa IRES TK reporter cell system and a transient transfection assay performed with a bicistronic Renilla-HCV IRES-firefly luciferase reporter in Huh7 cells. In contrast, ribozymes were inactive against IRES of encephalomyocarditis virus and human rhinovirus. Additionally, proteasome inhibitor MG132 exerted a dose-dependent inhibitory effect on HCV IRES-mediated translation but not on cap-dependent translation. These data suggest a principal role for PSMA7 in regulating HCV IRES activity, a function essential for HCV replication.
机译:核酶是小的催化RNA分子,可被改造为以序列特异性方式酶切切割RNA转录物,从而抑制相应基因产物的表达和功能。由于其简单的结构和特定于位点的切割活性,它们已被用作各种人类疾病的潜在治疗剂,包括丙型肝炎病毒(HCV)感染。我们设计了一个发夹状核酶(Rz3'X),该酶靶向HCV负链复制中间体,位于3'X尾部的40位。出人意料的是,发现Rz3'X在双顺反子细胞报告系统中诱导更昔洛韦(GCV)耐药菌落,该系统具有HCV内部核糖体进入位点(IRES)依赖性的单纯疱疹病毒胸苷激酶(TK)翻译。与对照载体转导的细胞相比,Rz3'X转导的抗GCV的HeLa报道细胞显示,IRES介导的HCV核心蛋白翻译显着减少。由于这些报告系统不包含HCV 3'X尾部序列,因此结果表明,Rz3'X可能通过另一个基因靶点偶然对HCV IRES活性产生了抑制作用。一种基于核酶裂解的靶基因鉴定新技术(cDNA末端的裂解特异性扩增)(M。Krüger,C。Beger,PJ Welch,JR Barber和F. Wong-Staal,Nucleic Acids Res。29:e94, 2001)揭示人20S蛋白酶体α亚基PSMA7 mRNA是被Rz3'X识别并切割的靶RNA。然后,我们显示了在两种测定系统中,针对PSMA7 RNA的其他核酶均抑制HCV IRES活性:HeLa IRES TK报告基因细胞系统中的GCV抗性,以及在Huh7细胞中用双顺反性Renilla-HCV IRES-萤火虫荧光素酶报道基因进行的瞬时转染测定。相反,核酶对脑心肌炎病毒和人鼻病毒的IRES没有活性。此外,蛋白酶体抑制剂MG132对HCV IRES介导的翻译具有剂量依赖性的抑制作用,但对帽依赖性翻译没有作用。这些数据表明PSMA7在调节HCV IRES活性(HCV复制必不可少的功能)中起主要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号